Truist Financial’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Truist Financial’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.68M	Buy	70,678 +1,010	+1%	+$59.2K	0.01%	952
2026 Q1	$3.77M	Buy	69,668 +64,596	+1,274%	+$3.6M	0.01%	981
2025 Q4	$284K	Buy	5,072 +7	+0.1%	+$363	﹤0.01%	2369
2025 Q3	$243K	Sell	5,065 -93	-2%	-$4.16K	﹤0.01%	2434
2025 Q2	$209K	Buy	5,158 +17	+0.3%	+$683	﹤0.01%	2404
2025 Q1	$225K	Sell	5,141 -436	-8%	-$19.2K	﹤0.01%	2303
2024 Q4	$240K	Buy	5,577 +93	+2%	+$4.23K	﹤0.01%	2284
2024 Q3	$243K	Buy	+5,484	New	+$235K	﹤0.01%	2249
2022 Q1	–	Sell	-7,688	Closed	-$355K	–	2871
2021 Q4	$355K	Sell	7,688 -2,443	-24%	-$116K	﹤0.01%	2246
2021 Q3	$481K	Sell	10,131 -7,986	-44%	-$397K	﹤0.01%	2027
2021 Q2	$938K	Sell	18,117 -2,800	-13%	-$141K	﹤0.01%	1688
2021 Q1	$1.05M	Sell	20,917 -121	-0.6%	-$6.45K	﹤0.01%	1564
2020 Q4	$1.09M	Sell	21,038 -6,881	-25%	-$329K	﹤0.01%	1430
2020 Q3	$1.21M	Buy	27,919 +9,583	+52%	+$420K	﹤0.01%	1292
2020 Q2	$788K	Buy	+18,336	New	+$758K	﹤0.01%	1396

Other funds holding XPH

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.34% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return

AWM

Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return

PAS

Park Avenue Securities New York $16B AUM 26.77% 1-Year Est. Return

CX Institutional Auburn, Indiana $3.46B AUM 21.89% 1-Year Est. Return

FFA

Fragasso Financial Advisors Sewickley, Pennsylvania $1.88B AUM 23.81% 1-Year Est. Return

IFG

Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Truist Financial's XPH Position: Q2 2026 in Review

Truist Financial increased its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 1.4% in Q2 2026, buying an estimated $59.2K and bringing the position to 70,678 shares worth $4.68M. The position accounts for 0.01% of the portfolio, ranked #952.

Truist Financial first reported a position in XPH in Q2 2020 and has held it in 15 quarters since. 24 funds tracked by Wall St. Rank hold XPH as of Q2 2026.

Truist Financial held 70,678 shares of State Street SPDR S&P Pharmaceuticals ETF worth $4.68M as of Q2 2026.
Truist Financial bought 1,010 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2026, an estimated $59.2K.
State Street SPDR S&P Pharmaceuticals ETF made up 0.01% of Truist Financial's portfolio in Q2 2026, its #952 holding.
Truist Financial first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2020 and has held it in 15 quarters since.
24 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.